JP2022550608A5 - - Google Patents

Info

Publication number
JP2022550608A5
JP2022550608A5 JP2022520780A JP2022520780A JP2022550608A5 JP 2022550608 A5 JP2022550608 A5 JP 2022550608A5 JP 2022520780 A JP2022520780 A JP 2022520780A JP 2022520780 A JP2022520780 A JP 2022520780A JP 2022550608 A5 JP2022550608 A5 JP 2022550608A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cells
fusion protein
disease
prion disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022520780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550608A (ja
JP7824873B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054140 external-priority patent/WO2021067864A1/en
Publication of JP2022550608A publication Critical patent/JP2022550608A/ja
Publication of JP2022550608A5 publication Critical patent/JP2022550608A5/ja
Application granted granted Critical
Publication of JP7824873B2 publication Critical patent/JP7824873B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520780A 2019-10-02 2020-10-02 プリオン病の治療のためのジンクフィンガータンパク質転写因子 Active JP7824873B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962909725P 2019-10-02 2019-10-02
US62/909,725 2019-10-02
US202063023197P 2020-05-11 2020-05-11
US63/023,197 2020-05-11
PCT/US2020/054140 WO2021067864A1 (en) 2019-10-02 2020-10-02 Zinc finger protein transcription factors for treatment of prion disease

Publications (3)

Publication Number Publication Date
JP2022550608A JP2022550608A (ja) 2022-12-02
JP2022550608A5 true JP2022550608A5 (https=) 2023-09-29
JP7824873B2 JP7824873B2 (ja) 2026-03-05

Family

ID=73013822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520780A Active JP7824873B2 (ja) 2019-10-02 2020-10-02 プリオン病の治療のためのジンクフィンガータンパク質転写因子

Country Status (5)

Country Link
US (1) US20230002459A1 (https=)
EP (1) EP4041271A1 (https=)
JP (1) JP7824873B2 (https=)
CN (1) CN114728037A (https=)
WO (1) WO2021067864A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250165443A (ko) 2023-02-17 2025-11-25 화이트헤드 인스티튜트 포 바이오메디칼 리서치 후성유전학적 변형 제조를 위한 조성물 및 방법
WO2025160155A1 (en) 2024-01-22 2025-07-31 The Broad Institute, Inc. Epigenetic targeting of prion diseases
WO2025194009A1 (en) * 2024-03-13 2025-09-18 Sangamo Therapeutics, Inc. Zinc finger proteins for treating prion disease

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420032A (en) 1991-12-23 1995-05-30 Universitge Laval Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
US5792632A (en) 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
DE69534629D1 (de) 1994-01-18 2005-12-29 Scripps Research Inst Derivate von zinkfingerproteinen und methoden
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
USRE39229E1 (en) 1994-08-20 2006-08-08 Gendaq Limited Binding proteins for recognition of DNA
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
ES2341926T3 (es) 1998-03-02 2010-06-29 Massachusetts Institute Of Technology Poliproteinas con dedos de cinc que tienen enlazadores mejorados.
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
WO2001073107A1 (en) * 2000-03-24 2001-10-04 University Of Massachusetts, A Public Institution Of The Commonwealt Of Massachusettes, As Represented By Its Amherst Campus Prion-free transgenic ungulates
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
US20050235369A1 (en) * 2001-03-28 2005-10-20 Yen Choo Gene regulation II
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
WO2003011016A2 (en) * 2001-07-31 2003-02-13 Stell Genetically modified cows having reduced susceptibility to mad cow disease
JP2005500061A (ja) 2001-08-20 2005-01-06 ザ スクリップス リサーチ インスティテュート Cnnについての亜鉛フィンガー結合ドメイン
ES2582091T3 (es) 2005-10-18 2016-09-09 Precision Biosciences Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
US20110023147A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of prion disorder-related genes in animals
US8586526B2 (en) 2010-05-17 2013-11-19 Sangamo Biosciences, Inc. DNA-binding proteins and uses thereof
HRP20200254T1 (hr) 2010-05-03 2020-05-29 Sangamo Therapeutics, Inc. Pripravci za povezivanje modula cink fingera
US20120225922A1 (en) * 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
CN102277356B (zh) * 2011-07-28 2012-10-03 扬州大学 一种山羊朊病毒基因敲除方法
KR102455249B1 (ko) 2016-08-24 2022-10-17 상가모 테라퓨틱스, 인코포레이티드 가공된 표적 특이적 뉴클레아제

Similar Documents

Publication Publication Date Title
JP2022550608A5 (https=)
Feng et al. Neutrophil extracellular traps exacerbate secondary injury via promoting neuroinflammation and blood–spinal cord barrier disruption in spinal cord injury
Kamei et al. Effect of an enhanced nose-to-brain delivery of insulin on mild and progressive memory loss in the senescence-accelerated mouse
Stowe et al. CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke
Birch The contribution of astrocytes to Alzheimer's disease
Corrigan et al. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains
AU2018225493B2 (en) Early detection of glial cell activation in neurodegenerative or neuroinflammatory diseases
Zhang et al. Cerebrolysin reduces astrogliosis and axonal injury and enhances neurogenesis in rats after closed head injury
Weber-Adrian et al. Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease
Yin et al. Optic nerve regeneration: A long view
JP2023511908A5 (https=)
JP7812364B2 (ja) 好中球性皮膚症の処置のための抗il-36r抗体
Li et al. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
Guo et al. Fasudil reduces β-amyloid levels and neuronal apoptosis in APP/PS1 transgenic mice via inhibition of the Nogo-A/NgR/RhoA signaling axis
Wu et al. Administration of rTMS alleviates stroke-induced cognitive deficits by modulating miR-409-3p/CTRP3/AMPK/Sirt1 Axis
JP2022551286A5 (https=)
US20240238363A1 (en) Oral peptide antagonists of multiple chemokine receptors for reversing loss of synapses and dendritic spines
Sussman et al. Neural tropomodulin: developmental expression and effect of seizure activity
Lefebvre-Roque et al. Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice
EP1670826B1 (de) Single-chain-antikörper gegen den 37 kda/67 kda lamininrezeptor als werkzeuge zur diagnose und therapie von prionerkrankungen und krebs, deren herstellung und verwendung
US10072051B2 (en) Anti-inflammatory lipopeptide and preparing method and application thereof
CN115475247A (zh) β2-微球蛋白或其抑制剂的制药用途
JP2023509187A5 (https=)
EP2991664A1 (de) Agenzien zur prävention und therapie von hiv und anderer viraler infektionen
Villa‐Cedillo et al. The mRVG‐9R peptide as a potential therapeutic vector to the central nervous system cells